According to Inke Medical's announcement, Liu Fangyi, the controlling shareholder of the company, has pledged 39 million shares of the company, accounting for 16.83% of its shares and 5.96% of the company's total share capital. The pledged shares are locked by executives. The pledge start date is October 12, 2026, and the expiration date is October 12, 2027. The pledger is Huatai Securities Co., Ltd., and the purpose of the pledge is personal capital requirements. After this pledge, Liu Fangyi pledged a total of 60.1 million shares, accounting for 25.94% of his shares and 9.18% of the company's total share capital. The risk of the pledge is manageable.

According to Inke Medical's announcement, Liu Fangyi, the controlling shareholder of the company, has pledged 39 million shares of the company, accounting for 16.83% of its shares and 5.96% of the company's total share capital. The pledged shares are locked by executives. The pledge start date is October 12, 2026, and the expiration date is October 12, 2027. The pledger is Huatai Securities Co., Ltd., and the purpose of the pledge is personal capital requirements. After this pledge, Liu Fangyi pledged a total of 60.1 million shares, accounting for 25.94% of his shares and 9.18% of the company's total share capital. The risk of the pledge is manageable.